ACB.TO - Aurora Cannabis Inc.

Toronto - Toronto Real Time Price. Currency in CAD
0.7200
+0.0400 (+5.88%)
At close: 04:00PM EDT
Stock chart is not supported by your current browser
Previous Close0.6800
Open0.6800
Bid0.7100 x 0
Ask0.7200 x 0
Day's Range0.6700 - 0.7200
52 Week Range0.6600 - 2.4900
Volume438,700
Avg. Volume754,639
Market Cap245.511M
Beta (5Y Monthly)3.00
PE Ratio (TTM)N/A
EPS (TTM)-8.3900
Earnings DateJun 07, 2023 - Jun 11, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.78
  • CNW Group

    Aurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference Call and File Related Year End Information

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its third quarter and full fiscal year 2023 on Wednesday, June 14, 2023 at 8:15 a.m. Eastern Time | 6:15 a.m. Mountain Time. The Company will report its financial results for the third quarter and full fiscal year 2023 before the opening of markets that same day. As a reminder, Fiscal 2023

  • Baystreet

    Stocks in play: Aurora Cannabis Inc

    Is launching a fresh lineup of innovative products, available to patients on Aurora Medical and consumers, ...

  • CNW Group

    Aurora Celebrates Summer with New Innovation Launching Across Canada

    Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, is launching a fresh lineup of innovative products, available to patients on Aurora Medical and consumers, at retailers across the country this summer. The company's ever-expanding portfolio includes new 1mg format, snackable edibles, premium resin vape carts with big, bold flavour, and a true-to-form signature hash. New flower products include Chemango Kush, an original strain from Occo, Aurora's estee

  • CNW Group

    Aurora and Ethypharm Reaffirm their Commitment to Promote Access to Medical Cannabis for French Patients

    Aurora Europe GmbH, a subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), and Ethypharm are pleased to announce that they have once again been selected by the French General Directorate of Health (DGS) as exclusive suppliers of dried medical cannabis flower until the end of the French trial period. The trial has recently been extended until March 2024.

  • Motley Fool

    The Most Likely Scenario for Aurora Cannabis Stock Doesn't Look Good

    Aurora Cannabis (NASDAQ: ACB) has been struggling for years. The stock is trading down to well under $1 per share, and another reverse stock split is inevitable for the company. Aurora Cannabis' stock price fell 96% over the past three years.

  • The Motley Fool

    2 TSX Stocks to Buy This Month and 1 to Avoid

    Investors looking to add quality growth stocks to their equity portfolio can consider buying Well Health right now. The post 2 TSX Stocks to Buy This Month and 1 to Avoid appeared first on The Motley Fool Canada.

  • Motley Fool

    Better Buy: Aurora Cannabis vs. Trulieve Cannabis

    One was once a favorite among cannabis investors, but the other could become the top cannabis contender.

  • The Motley Fool

    What’s Happening With Cannabis Stocks in May 2023?

    Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is more growth coming? The post What’s Happening With Cannabis Stocks in May 2023? appeared first on The Motley Fool Canada.

  • The Motley Fool

    Aurora Cannabis: Time to Light Up Your Portfolio?

    Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth prospects and fundamentals. The post Aurora Cannabis: Time to Light Up Your Portfolio? appeared first on The Motley Fool Canada.

  • Motley Fool

    This Troubled Stock Might Go Up in Smoke

    It's been roughly five years since Canada legalized cannabis, and it's been an unpleasant ride for investors in Aurora Cannabis (NASDAQ: ACB), one of Canada's leading growers and operators. The company became a penny stock after surging to over $120 per share in 2018. While some may hope for a tremendous comeback story, sometimes a business model just isn't good.

  • CNW Group

    Aurora Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs

    Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and a leading manufacturer and supplier of dried flower for medical patients worldwide, today announced the expansion of its portfolio in Germany with the launch of two new cannabis flower products for patients. Pedanios 27/1 FRG CA and Pedanios 29/1 SRD CA are dried cannabis flower with high tetrahydrocannabinol (THC) content. With these new therapeutic options now avai

  • The Motley Fool

    1 Marijuana Stock I’d Buy Over Aurora Cannabis

    Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio. The post 1 Marijuana Stock I’d Buy Over Aurora Cannabis appeared first on The Motley Fool Canada.

  • Motley Fool

    Better Growth Stock: Aurora Cannabis vs. Tilray Brands

    Marijuana stocks have fallen out of favor in the last two years. The Canadian producers Aurora Cannabis (NASDAQ: ACB) and Tilray Brands (NASDAQ: TLRY) are two of the most popular marijuana companies. Aurora Cannabis has been investors' favorite among pot stocks for a while.

  • CNW Group

    Aurora Cannabis Partners with Strainprint to Empower Patients on their Cannabis Journey

    Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced the launch of a new tracking program designed to support and empower cannabis patients on their wellness journey.

  • Baystreet

    Stocks in play: Aurora Cannabis

    Today announced a fresh lineup of innovative products. Coming soon to patients at Aurora Medical and ...

  • CNW Group

    Aurora Introduces Fresh Innovation for Spring

    Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced a fresh lineup of innovative products. Coming soon to patients at Aurora Medical and to consumers at retail stores across the country, the company's expanded portfolio includes newly developed cultivars, strain-specific gummies and aromatic vapes. Flower products include two original strains from Occo, Aurora's esteemed breeding program: Pink Diesel '71 and Moon Berry.

  • CNW Group

    Aurora Repurchases ~$22 Million Principal Amount of Convertible Notes, Saving $1.2 Million in Annualized Interest Payments and Leaving ~$79 Million (US$59) of Notes Outstanding; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry

    Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $22.3 million (US$16.6 million) principal amount of its convertible senior notes ("Notes") in multiple transactions since the start of April 2023 at a total cash cost, including accrued interest, of $16.7 million (US$12.4 million) and $5.3 million (US$4.0 million), including accrued interest, satisfied

  • Motley Fool

    How Aurora Cannabis, Curaleaf, and SNDL Stack Up on 420 Day 2023

    April 20th has a special significance for the cannabis industry. Three of those companies have especially attracted investors' attention in recent years -- Aurora Cannabis (NASDAQ: ACB), Curaleaf Holdings (OTC: CURLF), and SNDL (NASDAQ: SNDL) (formerly known as Sundial Growers). Aurora Cannabis is the worst of the group, with its share price plunging more than 80%.

  • Motley Fool

    3 Former High-Flying Stocks Down 92% to 99% That Billionaire Investors Can't Stop Buying

    Despite losing most of their value, these former Wall Street darlings have been popular buys among billionaire money managers.

  • CNW Group

    Aurora and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients

    Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and MedReleaf Australia today announced the launch of IndiMed Tempo 26, a range of new higher THC dried cannabis products for qualified patients under the MedReleaf Concession Scheme (MCS). Tempo 26 will add to the portfolio of products available, giving doctors the ability to prescribe from a wider range of options for medical cannabis patients.

  • Motley Fool

    Which Canadian Cannabis Company Will Be the Next Takeover Target?

    The Canadian government's decision to license over 1,000 cannabis producers, along with its inability to rein in black market operators, has been an unmitigated disaster for the country's top legal cultivators. Despite billions of dollars being spent on state-of-the-art cultivation facilities, brick-and-mortar retail outlets, and virtual storefronts, Canada's largest cannabis companies have been losing money at an alarming rate due to a vast oversupply of product in the country. In turn, profit margins have cratered across the industry, spurring some notable cannabis companies like Aurora Cannabis (NASDAQ: ACB), SNDL, and Tilray Brands to diversify into non-cannabis businesses like alcohol and vegetables in an effort to become cash-flow-positive.

  • The Motley Fool

    Are Cannabis Stocks a Good Buy in April 2023?

    Here's why cannabis stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets for TSX investors. The post Are Cannabis Stocks a Good Buy in April 2023? appeared first on The Motley Fool Canada.

  • Motley Fool

    Better Buy: Aurora Cannabis vs. Green Thumb Industries

    Marijuana stocks have performed poorly over the last two years. Cannabis analytics firm BDSA estimates that global cannabis sales will reach $57 billion by 2026, a 13% annual growth forecast from $30 billion in 2021, with bulk of this growth expected to be driven by the Canadian and American markets. Investment opportunities seem lucrative, and investors with a higher risk appetite might stand to profit handsomely in the long run in this volatile industry.

  • Motley Fool

    Why Aurora Cannabis Stock Is Slumping Today

    Canadian marijuana company Aurora Cannabis (NASDAQ: ACB) is having another bad day. The pot seller's shares were down by a noteworthy 4.34% on moderate volume as of 2:05 p.m. ET on Monday. Since the start of the year, Aurora's stock has now shed 27.5% of its value, and the share price has fallen well below the Nasdaq's $1 bid requirement, triggering a noncompliance notice from the exchange last month.

  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Aurora announced the repurchase of convertible senior notes worth approximately $47 million, saving the company $2.6 million in annualized interest payments. Jushi Holdings reported preliminary Q4 and record full year 2022 financial results. Curaleaf announced $20 million acquisition in Key Takeaways; Psychedelic Sector Awakn’s proprietary treatment protocol for alcohol use disorder […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared fi